Aster DM Healthcare Limited (ASTERDM)

Healthcare · Healthcare Services · NSE · Updated 15 July 2026

₹813.2 ↑ 35.86% (1Y)

🎯 Key Takeaways

Aster DM Healthcare Limited is undergoing a strategic transformation following its merger with Quality Care India Limited, now operating under the name Aster DM Quality Care Limited. The company has executed a capital restructuring involving share allotment to legacy shareholders and is actively reshaping its leadership team post-merger.
Revenue declined 3.4% QoQ to ₹1,050 in Q3FY25.
⚠️ 1) Integration risk from the merger with Quality Care India Limited remains elevated, as evidenced by leadership turnover and the need for structural

Market Cap

₹39,048

P/E Ratio

7.1

Div Yield

0.00%

Promoter

0.0%

✨ Ask AI About ASTERDM 📊 Interactive Charts

📖 The Story

Aster DM Healthcare Limited is undergoing a strategic transformation following its merger with Quality Care India Limited, now operating under the name Aster DM Quality Care Limited. The company has executed a capital restructuring involving share allotment to legacy shareholders and is actively reshaping its leadership team post-merger. Financially, it is transitioning from a period of volatility in FY24 to emerging profitability in FY25, with recent quarters showing improved operational performance and margins.

📰 What's Happening

The company completed a name change to Aster DM Quality Care Limited effective 3 July 2026, formalizing its integration with Quality Care India Limited following NCLT approval. A significant board reshuffle took effect on 1 July 2026, appointing Varun Khanna as Managing Director & Group CEO and adding six independent directors, while several legacy directors resigned. Senior management elevations were also announced across India and Bangladesh operations, alongside a CFO transition with Hitesh Dhaddha stepping down as CFO and M&A officer effective 18 July 2026. Additionally, the ESOP scheme was amended to cover up to 1.53 crore shares with revised pricing and vesting terms administered by the Nomination and Remuneration Committee.

Source: Stock Announcements

📊 Quarterly Results (₹ Cr)

Metric	Q4FY23	Q1FY24	Q2FY24	Q3FY24	Q4FY24	Q1FY25	Q2FY25	Q3FY25
Revenue	3,262	3,215	3,317	3,711	974	1,002	1,086	1,050
Operating Profit	520	397	331	572	163	212	255	198
OPM %	15.5%	12.1%	11.4%	15.2%	16.4%	16.3%	20.2%	18.0%
Net Profit	183	20	-15	209	-2	5,152	106	64
EPS	₹3.43	₹0.10	₹-0.62	₹3.60	₹-0.48	₹103.34	₹1.94	₹1.14

The company has shifted from inconsistent profitability in FY24 — including a net loss of ₹2 crore in Q4FY24 — to a net profit of ₹64 crore in Q3FY25, signaling stabilization in operations. Revenue growth has moderated slightly in recent quarters, with Q3FY25 revenue at ₹1,050 crore down from ₹1,086 crore in Q2FY25, but operating margin improved to 18% from 20.2% in the prior quarter. The sharp decline in EPS from ₹103.34 in Q1FY25 to ₹1.14 in Q3FY25 reflects a 90% equity dilution from the merger and share allotment, not operational deterioration. Profitability trends align with management's focus on operational efficiency, as OPM held steady at 18% in Q3FY25 despite revenue softness.

🔮 Management Outlook & What's Next

Management has not provided explicit forward guidance in the reviewed filings, but the leadership changes and structural adjustments suggest an ongoing focus on integration execution and governance stability post-merger. The board reshuffle and ESOP amendments indicate a deliberate effort to align incentives and governance with the new corporate structure. No formal financial targets or growth projections were disclosed in the latest board meeting filings.

Extracted from official company announcements. Not StockFin.ai's opinion.

⚖️ Peer Comparison — Healthcare Services

Company	MCap (₹ Cr)	P/E	ROCE	ROE	D/E
Apollo Hospitals Enterprise Limited	1.16 L Cr	64.5	20.5%	21.9%	0.64
Max Healthcare Institute Limited	1.02 L Cr	101.2	—	—	—
Fortis Healthcare Limited	72,752	94.6	—	—	—
Aster DM Healthcare Limited	39,048	7.1	—	—	—
Narayana Hrudayalaya Ltd.	37,625	47.7	—	—	—
Global Health Limited	33,405	65.8	—	—	—
Krishna Institute of Medical Sciences Limited	30,477	80.3	—	—	—
Dr. Lal Path Labs Ltd.	26,871	63.6	—	—	—
Syngene International Limited	18,295	36.3	—	—	—
Dr. Agarwal's Health Care Limited	14,266	88.8	14.9%	6.8%	0.13

🔗 Peer Stock Analyses

APOLLOHOSP MAXHEALTH FORTIS NH MEDANTA

⚠️ Risk Factors

1) Integration risk from the merger with Quality Care India Limited remains elevated, as evidenced by leadership turnover and the need for structural realignment. 2) Margin pressure in Q2FY25 (OPM at 20.2%) followed by a decline to 18% in Q3FY25 indicates potential execution challenges in sustaining profitability amid revenue softness. 3) The sharp EPS volatility — from ₹103.34 in Q1FY25 to ₹1.14 in Q3FY25 — highlights accounting dilution effects that may confuse investors despite underlying operational recovery. 4) The absence of formal guidance or clear communication on post-merger synergies introduces uncertainty around management's ability to deliver on integration milestones.

📋 Recent Filings

🧠 Analyst's Read

The company is in a critical post-merger stabilization phase, with financial results showing early signs of recovery but still influenced by structural changes. Investors should monitor execution of the new leadership team, clarity on integration synergies, and whether margin trends stabilize in upcoming quarters. The lack of forward guidance necessitates caution, with execution risks outweighing current financial metrics.

Based on filing content and financial data. Not a recommendation.

Read the full analysis

Quarterly trends, balance sheet, cash flow, peer comparison, and AI insights — sign up free to unlock.

2 free AI queries per day.

✨ Deep Dive with AI on ASTERDM

Data sourced from stock announcements. Analysis generated by StockFin.ai.
For informational purposes only — not investment advice. Updated 2026-07-15.

📡 Get AI alerts when ASTERDM files new disclosures

Track ASTERDM filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track ASTERDM — Free

Free account · 2 AI queries/day